Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Sep;90(9):921-925.
doi: 10.1007/s00115-019-0759-6.

[Prevention of cognitive decline and dementia by treatment of risk factors]

[Article in German]
Affiliations
Review

[Prevention of cognitive decline and dementia by treatment of risk factors]

[Article in German]
Claus Escher et al. Nervenarzt. 2019 Sep.

Abstract

Background: In Germany, approximately 1.6 million people are currently suffering from dementia. The prevalence of the disease is expected to double by 2060. To date there is no treatment that can prevent the onset of dementia. For this reason, the development of prevention strategies for cognitive decline and dementia is crucial.

Objective: Presentation of studies on dementia prevention by treatment of arterial hypertension. Overview of current multidomain interventional studies on dementia prevention.

Material and methods: Narrative review.

Results: Whereas in three previous randomized controlled trials on antihypertensive treatment a reduction of dementia risk could not be found, the recent SPRINT-MIND study demonstrated a reduced risk of mild cognitive impairment (MCI) and in the trend for dementia by intensified hypotensive treatment. Multidomain interventional studies suggest preventive effects, particularly in specific risk groups and also highlight the challenge of adherence to lifestyle modifications.

Conclusion: The treatment of modifiable risk factors can have a preventive effects on cognitive decline and dementia. More research is needed to identify subgroups with the greatest likelihood of benefits.

Keywords: Alzheimer’s disease; Arterial hypertension; Cardiovascular events; Interventional studies; Stroke.

PubMed Disclaimer

References

    1. J Hypertens. 2003 May;21(5):875-86 - PubMed
    1. J Alzheimers Dis. 2006;9(3 Suppl):61-70 - PubMed
    1. Lancet Neurol. 2008 Aug;7(8):683-9 - PubMed
    1. Cochrane Database Syst Rev. 2009 Oct 07;(4):CD004034 - PubMed
    1. JAMA. 1991 Jun 26;265(24):3255-64 - PubMed

MeSH terms

Substances

LinkOut - more resources